QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 intercure-h1-eps-001-up-from-000-yoy-sales-36292m-miss-66530m-estimate

Intercure (NASDAQ:INCR) reported quarterly earnings of $0.01 per share. This is a 700 percent increase over earnings of $0.00 p...

 intercure-enters-premium-us-cannabis-market-with-ishi-deal

InterCure Ltd. (NASDAQ: INCR) acquires Botanico Ltd., known as ISHI, to strengthen its global cannabis portfolio.

 intercure-acquires-botanico-aka-ishi-in-all-stock-deal-worth-492m-ordinary-shares-to-expand-cannabis-portfolio

Acquisition of leading cannabis company marks major milestone in InterCure's commercial expansion strategy, bringing access...

Core News & Articles

https://www.marijuanamoment.net/gop-led-congressional-panel-demands-investigation-on-bidens-marijuana-rescheduling-process-citi...

Core News & Articles

https://www.marijuanamoment.net/trump-white-house-invites-proposal-on-federal-marijuana-legalization-activist-says/

 are-investors-missing-the-forest-35-stock-drop-masks-the-international-potential-of-this-weed-company

InterCure Ltd. has shown resilience in its H1 2024 performance despite facing significant challenges according to research by Z...

 intercure-h1-revenue-nis125733m-down-from-nis208614m-yoy-adjusted-ebitda-nis20829m-down-from-nis29669m-yoy

Revenues for the first half of 2024 were affected by damages caused by the terrorist attack on October 7, 2023, and the war i...

 european-cannabis-companies-race-to-the-nasdaq-1b-in-tax-break-on-the-horizon

Some European cannabis companies are already planning initial public offerings (IPOs) on the Nasdaq, encouraged by the prospect...

 asset-light-expansion-into-8b-german-market-adds-potential-to-this-cannabis-stock-on-nasdaq

The potential rescheduling of cannabis in the U.S.

 intercure-reports-strong-fy2023-performance-paves-the-way-for-global-expansion

"Explore InterCure's FY2023 financial results revealing robust revenue growth and operational resilience amidst challen...

 intercure-fy23-revenue-nis356m
InterCure FY23 Revenue NIS356M
05/01/2024 12:55:21

 this-israeli-cannabis-operator-anticipates-954m-in-revenue-despite-gaza-conflict

Discover how InterCure thrives in 2023 with $95.4M revenue, despite challenges, and plans for global expansion into the U.S. an...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION